Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
In regional hyperthermic perfusion with melphalan for patients with malignant melanoma of the leg, plasma leakage between the perfusion circuit and the systemic circulation was 4-7 ml X min-1. The melphalan concentration in the perfusate was biphasic, with half-lives of 8-12 mins for the initial phase and 19-28 mins for the second phase, after the first dose. After a second dose, the corresponding values were 11-13 and 26-34 mins. The highest concentration in general circulation was 0.38 micrograms X ml-1.
D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects / Q000379:methods*; D003131:Combined Modality Therapy; D006207:Half-Life; D006801:Humans; D006979:Hyperthermia, Induced; D007457:Iodine Radioisotopes / Q000097:blood; D007866:Leg; D008545:Melanoma / Q000097:blood / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage* / Q000097:blood
D007457:Iodine Radioisotopes; D008558:Melphalan